Insider Trading & Ownership - Leonard Frank X

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Leonard Frank X
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-11-01
Sale
2024-11-04
4:34 pm
NovoCure LtdNVCRLeonard Frank X
EVP, Pres., Novocure Oncology
598$15.94$9,531161,236
(Direct)
View
2024-03-01
Sale
2024-03-05
4:08 pm
NovoCure LtdNVCRLeonard Frank X
EVP, Pres., Novocure Oncology
2,519$16.02$40,358160,098
(Direct)
View
2024-02-28
Sale
2024-02-29
4:38 pm
NovoCure LtdNVCRLeonard Frank X
EVP, Pres., Novocure Oncology
2,078$16.14$33,545318,965
(Direct)
View
2023-03-03
Sale
2023-03-07
4:52 pm
NovoCure LtdNVCRLeonard Frank X
President, CNS Cancers US
13,609$75.55$1,028,16554,284
(Direct)
View
2023-03-02
Sale
2023-03-06
4:37 pm
NovoCure LtdNVCRLeonard Frank X
President, CNS Cancers US
2,903$76.95$223,39367,893
(Direct)
View
2023-03-02
Sale
2023-03-03
4:13 pm
NovoCure LtdNVCRLeonard Frank X
President, CNS Cancers US
4,107$75.38$309,57858,988
(Direct)
View
2023-03-01
Sale
2023-03-02
5:01 pm
NovoCure LtdNVCRLeonard Frank X
President, CNS Cancers US
1,684$76.36$128,59494,066
(Direct)
View
2023-01-05
Sale
2023-01-09
6:21 pm
NovoCure LtdNVCRLeonard Frank X
President, CNS Cancers US
39,507$112.25$4,434,65474,299
(Direct)
View
2022-10-13
Sale
2022-10-17
4:35 pm
NovoCure LtdNVCRLeonard Frank X
President, CNS Cancers US
6,754$76.01$513,37243,626
(Direct)
View
2022-10-06
Sale
2022-10-07
4:16 pm
NovoCure LtdNVCRLeonard Frank X
President, CNS Cancers US
6,754$84.37$569,83550,380
(Direct)
View
2022-09-29
Sale
2022-09-30
4:20 pm
NovoCure LtdNVCRLeonard Frank X
President, CNS Cancers US
6,754$77.35$522,42257,134
(Direct)
View
2022-09-22
Sale
2022-09-26
4:19 pm
NovoCure LtdNVCRLeonard Frank X
President, CNS Cancers US
6,754$77$520,05863,888
(Direct)
View
2022-09-15
Sale
2022-09-19
4:10 pm
NovoCure LtdNVCRLeonard Frank X
Chief Development Officer
12,271$88.52$1,086,22276,159
(Direct)
View
2022-09-08
Sale(A)
2022-09-13
4:15 pm
NovoCure LtdNVCRLeonard Frank X
Chief Development Officer
6,754$81.48$550,31677,396
(Direct)
View
2022-09-09
Sale
2022-09-12
4:32 pm
NovoCure LtdNVCRLeonard Frank X
Chief Development Officer
1,863$88$163,94484,150
(Direct)
View
2022-09-06
Sale
2022-09-07
4:27 pm
NovoCure LtdNVCRLeonard Frank X
Chief Development Officer
1,384$78.57$108,74186,013
(Direct)
View
2022-09-01
Sale
2022-09-06
4:19 pm
NovoCure LtdNVCRLeonard Frank X
Chief Development Officer
14,796$77.5$1,146,63487,397
(Direct)
View
2022-08-02
Sale
2022-08-03
4:44 pm
NovoCure LtdNVCRLeonard Frank X
Chief Development Officer
414$69.66$28,839102,193
(Direct)
View
2022-03-08
Sale
2022-03-09
4:55 pm
NovoCure LtdNVCRLeonard Frank X
Chief Development Officer
744$70.1$52,154102,295
(Direct)
View
2022-03-03
Sale
2022-03-07
6:14 pm
NovoCure LtdNVCRLeonard Frank X
Chief Development Officer
1,485$72.97$108,359138,394
(Direct)
View
2021-09-02
Sale
2021-09-07
4:39 pm
NovoCure LtdNVCRLeonard Frank X
Chief Development Officer
540$138.23$74,64587,153
(Direct)
View
2021-08-02
Sale
2021-08-04
5:20 pm
NovoCure LtdNVCRLeonard Frank X
Chief Development Officer
1,041$149.39$155,52089,158
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-06-28
Option Award
2024-08-06
4:17 pm
N/A
N/A
NovoCure LtdNVCRLeonard Frank X
EVP, Pres., Novocure Oncology
1,736$12.24161,834
(Direct)
View
2024-02-27
Option Award
2024-02-29
4:38 pm
2025-02-27
2034-02-26
NovoCure LtdNVCRLeonard Frank X
EVP, Pres., Novocure Oncology
258,597$16.3318,965
(Direct)
View

Ownership
2024-01-12
4:57 pm
N/A
N/A
NovoCure LtdNVCRLeonard Frank X
EVP, Pres., Novocure Oncology
0$0227,173
(Direct)
View
2023-03-03
Option Award
2023-03-06
4:37 pm
N/A
N/A
NovoCure LtdNVCRLeonard Frank X
President, CNS Cancers US
11,808$067,893
(Direct)
View
2023-02-28
Option Award
2023-03-02
5:01 pm
N/A
N/A
NovoCure LtdNVCRLeonard Frank X
President, CNS Cancers US
18,621$094,066
(Direct)
View
2023-02-28
Option Award
2023-03-02
5:01 pm
2024-02-28
2033-02-27
NovoCure LtdNVCRLeonard Frank X
President, CNS Cancers US
30,971$76.9794,066
(Direct)
View
2023-01-05
Exercise
2023-01-09
6:21 pm
N/A
N/A
NovoCure LtdNVCRLeonard Frank X
President, CNS Cancers US
7,183$21.1574,299
(Direct)
View
2023-01-05
Exercise
2023-01-09
6:21 pm
N/A
2025-02-23
NovoCure LtdNVCRLeonard Frank X
President, CNS Cancers US
35,209$074,299
(Direct)
View
2023-01-05
Exercise
2023-01-09
6:21 pm
N/A
N/A
NovoCure LtdNVCRLeonard Frank X
President, CNS Cancers US
5,517$7.1574,299
(Direct)
View
2023-01-05
Exercise
2023-01-09
6:21 pm
N/A
N/A
NovoCure LtdNVCRLeonard Frank X
President, CNS Cancers US
7,826$14.3774,299
(Direct)
View
2023-01-05
Exercise
2023-01-09
6:21 pm
N/A
N/A
NovoCure LtdNVCRLeonard Frank X
President, CNS Cancers US
7,500$11.4674,299
(Direct)
View
2022-11-01
Option Award
2022-11-03
4:42 pm
N/A
N/A
NovoCure LtdNVCRLeonard Frank X
President, CNS Cancers US
6,830$062,065
(Direct)
View
2022-11-01
Option Award
2022-11-03
4:42 pm
2023-11-01
2032-10-31
NovoCure LtdNVCRLeonard Frank X
President, CNS Cancers US
11,609$73.262,065
(Direct)
View
2022-09-15
Exercise
2022-09-19
4:10 pm
N/A
2027-02-21
NovoCure LtdNVCRLeonard Frank X
Chief Development Officer
5,517$076,159
(Direct)
View
2022-09-15
Exercise
2022-09-19
4:10 pm
N/A
N/A
NovoCure LtdNVCRLeonard Frank X
Chief Development Officer
5,517$7.1576,159
(Direct)
View
2022-07-05
Option Award
2022-07-07
5:46 pm
N/A
N/A
NovoCure LtdNVCRLeonard Frank X
Chief Development Officer
312$59.08102,607
(Direct)
View
2022-03-03
Option Award
2022-03-07
6:14 pm
N/A
N/A
NovoCure LtdNVCRLeonard Frank X
Chief Development Officer
17,371$0138,394
(Direct)
View
2022-03-03
Option Award
2022-03-07
6:14 pm
2023-03-01
2032-02-29
NovoCure LtdNVCRLeonard Frank X
Chief Development Officer
35,355$80.59138,394
(Direct)
View
2021-07-06
Option Award
2021-07-08
5:36 pm
N/A
N/A
NovoCure LtdNVCRLeonard Frank X
Chief Development Officer
154$137.1290,199
(Direct)
View
2021-03-02
Option Award
2021-03-04
5:55 pm
N/A
2031-03-01
NovoCure LtdNVCRLeonard Frank X
Chief Development Officer
24,712$0107,380
(Direct)
View
2021-02-27
Exercise
2021-03-02
4:12 pm
2021-02-27
N/A
NovoCure LtdNVCRLeonard Frank X
Chief Development Officer
1,465$083,098
(Direct)
View
2021-02-27
Exercise
2021-03-02
4:12 pm
N/A
N/A
NovoCure LtdNVCRLeonard Frank X
Chief Development Officer
1,465$149.183,098
(Direct)
View

Ownership
2020-09-10
8:20 pm
N/A
N/A
NovoCure LtdNVCRLeonard Frank X
Chief Development Officer
0$0223,330
(Direct)
View
2020-09-01
Option Award
2020-09-04
4:38 pm
N/A
2030-08-31
NovoCure LtdNVCRLeonard Frank X
Chief Development Officer
17,240$092,969
(Direct)
View
(A) Indicate amendment filing.